| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |